Trials
Search / Trial NCT06430944

Comparative Study Between Single and Double Limb Hip Spica Cast in Fracture Femur in Young Children

Launched by KASR EL AINI HOSPITAL · May 24, 2024

Apply for Trial

Trial Information

Current as of February 19, 2025

Completed

Keywords

ClinConnect Summary

Femoral fractures are frequent in children and compose 1% to 2% of all pediatric fractures. Conservative management is associated with good results, whether by single or double-limb cast fixations. We aim to compare both procedures regarding functional outcomes, complications, and parents' satisfaction. Eighty-four children were eligible to be included in our study; 42 underwent single limb spica casts, and the other 42 patients underwent double limb spica casts. Both groups had similar baseline characteristics like age, gender, fracture side, and fracture classification.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • children aged 2 to 6 years
  • • Children with femur shaft fractures
  • Exclusion Criteria:
  • • Children younger than 2 years or older than 6 years
  • • Articular fractures or fractures that cant be managed with a cast
  • • Old fractures older than 3 weeks

About Kasr El Aini Hospital

Kasr El Aini Hospital, a prestigious medical institution affiliated with Cairo University, is dedicated to advancing healthcare through innovative clinical research. With a commitment to excellence, the hospital serves as a leading sponsor of clinical trials, leveraging its state-of-the-art facilities and a multidisciplinary team of healthcare professionals. The institution focuses on a diverse range of therapeutic areas, aiming to improve patient outcomes and contribute to the global medical community. By fostering collaboration and adhering to the highest ethical standards, Kasr El Aini Hospital plays a pivotal role in the development of new treatments and therapies.

Locations

Cairo, Manial, Egypt

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0